MPC5 Cells
€550.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | MPC-5 (also known as “MPC5” or “Mouse Podocyte Clone-5”) is a conditionally immortalized mouse podocyte cell line widely used to study podocyte differentiation and injury mechanisms in vitro. The cells originate from kidney podocytes of a transgenic H2Kb-tsA58 “Immortomouse” background and carry a temperature-sensitive SV40 large T antigen (SV40LT) system that enables controlled switching between proliferation and differentiation states. Under permissive growth conditions, MPC-5 cells are typically expanded at 33 °C in the presence of interferon-γ, which supports SV40LT-driven proliferation. To induce differentiation, cells are shifted to 37 °C and interferon-γ is removed, leading to growth arrest and acquisition of podocyte-like features. During differentiation, MPC-5 cells undergo pronounced cytoskeletal reorganization and process formation; WT1 is commonly detected across states, while synaptopodin expression is associated with the differentiated phenotype. Functionally, differentiated cells have been shown to respond to bradykinin with intracellular calcium signaling, supporting their use as a podocyte signaling model. MPC-5 is frequently applied in mechanistic studies of podocyte cytoskeletal dynamics, adhesion/contact remodeling, and cellular stress responses. The line is also broadly used for podocyte-injury paradigms relevant to diabetic kidney disease, where high-glucose exposure is commonly employed to model oxidative, inflammatory, and apoptotic stress and to monitor podocyte readouts (e.g., WT1 and slit diaphragm–associated markers as experimental endpoints). In addition, molecular regulatory layers have been studied in MPC-5 injury settings; for example, miR-204-3p has been reported to modulate high-glucose–induced dysfunction by targeting the bradykinin B2 receptor (Bdkrb2) pathway. |
|---|---|
| Organism | Mouse |
| Tissue | Kidney |
| Disease | Normal |
| Synonyms | MPC-5, Mouse Podocyte Clone-5 |
Characteristics
| Breed/Subspecies | (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse |
|---|---|
| Age | Unspecified |
| Gender | Unspecified |
| Cell type | Podocyte |
| Growth properties | Adherent |
Regulatory Data
| Citation | MPC5 (Cytion catalog number 305481) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_AS87 |
Biomolecular Data
| Viruses | Transformant: Simian virus 40 (SV40) |
|---|
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305481-221024 | Certificate of Analysis | 23. May. 2025 | 305481 |
Material Transfer Agreement
If you intend to use Cytion cell lines solely for internal research at a single research site, please complete and sign our Material Transfer Agreement (MTA) and submit it along with your order.
For any commercial applications - including but not limited to fee-for-service work, quality control testing, product release, diagnostic use, or regulatory studies - please complete the Intended Use Form so we can prepare a suitable agreement tailored to your project.
Please note: The MTA applies only to certain cell lines. If this notice and the MTA document appear on a product page, the agreement is applicable. For cell lines not covered by the MTA, no reference to the agreement will be shown. The MTA is not valid for customers in the Americas, China, or Taiwan. Please contact our U.S. entity to receive the appropriate agreement.